ReviewClinics and practice2026

Serum or Plasma Oncostatin M for Predicting Primary Non-Response to Tumor Necrosis Factor-α Antagonist Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Maxwell A Barffour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.